Do you have an innovation or invention that needs further development, but its practical feasibility and/or the (commercial) exploitation opportunities are still uncertain?
Then you may be eligible for funding from the Academic Proof of Concept Fund Amsterdam (APCA)!
In order to attract the significant investment required for the development of knowledge, an innovative idea or invention into a marketable product, it is often necessary to demonstrate the feasibility and/or market opportunities first, by means of a so-called Proof of Concept (PoC) study.
In a PoC study the conceptual, social, technical and/or economic feasibility is determined. For example, by addressing one of the following questions:
The PoC study can also be used for targeted identification of potential business partners or a specific market research. It only makes sense to develop the idea or invention further, when the feasibility is sufficiently assured.
An application to the APCA fund may not exceed € 45,000, of which 50% is a loan and 50% needs to be matched (cash or in kind) by the applicant. At least 75% of the cost of the POC study should then be spent at one of the affiliated Amsterdam knowledge institutes to examine the feasibility. The contribution from the Fund is a loan with soft conditions.
This facility is available to employees of AMC, HvA, UvA, VU, VUmc and NKI for studies conducted by the research institutions, but also for companies the APCA Fund may be an interesting option to validate a premature idea that normally would remain ‘on the shelf’, using the high quality academic knowledge and research infrastructure of the affiliated Amsterdam knowledge institutes. Companies need to match at least half of their contribution in cash, because of the requirement to spend at least 75% of APCA financing at one of the affiliated knowledge institutions in Amsterdam.
Read more about the first APCA grants IXA has awarded to two AMC projects “Applying histatin 1 to improve integration of dental implants” by Jan Stap and Irene van Dijk and “Identification of compounds that interfere with protein aggregation in Huntington’s Disease” by Eric Reits.
Earlier granted PoC studies were among others to Jeroen Pronk of Faculty of Behavioral and Movement Sciences of VU for the Pestplotter which is now ready to be implemented into the school.
This project is made possible by the City of Amsterdam.
Teachers from the department of medical informatics of Amsterdam UMC have developed an online platform to gather and visualize structured curriculum information, called act-E. Education managers, teachers and students use this platform to gain insights regarding their curricula that could never be viewed as easily before. These insights help them to have an informed conversation […]News
Chronic kidney diseases are a severe and growing worldwide problem with a lack of effective treatments often leading to dialysis, transplantation, and high costs to health care systems. Now, a monoclonal antibody, named BION-1301 (anti-APRIL), is being developed to treat patients with IgA nephropathy. BION-1301 is a potential disease-modifying approach to prevent the formation of […]News
VU alumni International Business Administration Michael Musandu and Ugnius Rimsa founded Lalaland in 2019. The startup generates and hyper personalizes full human body models from head to toe by using AI. As a result, models are available in different ethnicities, sizes and ages, allowing customers to always recognize themselves in the clothing of their choice. […]News